TY  - JOUR

T1  - Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.

JO  - Gynecol Oncol

PY  - 2016/10/15

AU  - Winter MC

AU  - Tidy JA

AU  - Hills A

AU  - Ireson J

AU  - Gillett S

AU  - Singh K

AU  - Hancock BW

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1016/j.ygyno.2016.10.001

Y2  - 2025/10/10

ER  -